GABA Gabather AB

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · gabather.com

0.0258SEK-1.53%Mkt Cap: 1.51M $P/E: —3d ago

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, an…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap1.51M USD

Enterprise Value1.15M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-444.97K USD

Revenue/Share—

Last Price0.0258 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees2

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0010869552

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B12.90

EPS (TTM)-0.02

EPS (Forward)—

52W Range

0.02304% of range0.1000

52W High0.1000 SEK

52W Low0.0230 SEK

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-702.72%

ROA-86.87%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-690.99K USD

CapEx (TTM)—

FCF Margin—

FCF Yield-32.61%

Net Debt-352.48K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio1.46

Quick Ratio1.40

Book Value/Sh0.0020 SEK

Cash/Share0.0060 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:4

Split DateMar 22, 2018

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.610.49M

Float502.12M

Insiders8.96%

Institutions6.69%

Technical

SMA 500.0306 (-15.6%)

SMA 2000.0355 (-27.3%)

Beta-0.75

S&P 52W Chg14.58%

Avg Vol (30d)2.37M

Avg Vol (10d)2.07M

Technical Indicators

RSI (14)41.5

MACD-0.0014

MACD Signal-0.0014

MACD Hist.-0.0000

BB Upper0.0313 SEK

BB Middle0.0279 SEK

BB Lower0.0245 SEK

BB Width24.28%

ATR (14)0.0035 SEK

Vol Ratio (20d)2.93x